- Home
- SRTA vs AUTL Comparison
SRTA vs AUTL Comparison
Compare SRTA & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRTA | AUTL |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.7M | 368.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SRTA | AUTL |
|---|---|---|
| Price | $4.37 | $1.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.63 | ★ $8.33 |
| AVG Volume (30 Days) | 990.2K | ★ 3.9M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $268,618,000.00 | $51,128,000.00 |
| Revenue This Year | N/A | $658.11 |
| Revenue Next Year | $39.24 | $91.34 |
| P/E Ratio | $9.58 | ★ N/A |
| Revenue Growth | 70.11 | ★ 406.67 |
| 52 Week Low | $2.35 | $1.11 |
| 52 Week High | $6.02 | $3.11 |
Technical Indicators
Market Signals| Indicator | SRTA | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.56 |
| Support Level | N/A | $1.31 |
| Resistance Level | N/A | $1.61 |
| Average True Range (ATR) | 0.00 | 0.09 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 85.37 |
Price Performance
Historical ComparisonAbout SRTA Strata Critical Medical Inc. Class A Common Stock
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.